Patents with end-stage renal disease depend on the patency of their dialysis access. As these patients have only finite access options, and no access lasts indefinitely, it is imperative that each access should be maintained for as long as possible. This report describes a case of salvage of an upper arm fistula by repeated angioplasty of the collateral veins after the main out flow vein was occluded and could not be recanalyzed.
BeathardG.A., ArnoldP., JacksonJ., LitchfieldT.Aggressive treatment of early fistula failure.Kidney Int2003; 64: 1487–94.
3.
US Renal Data System.USRDS 2001 Annual Report: Atlas of End Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2005.
4.
DOQI Clinical Practice Guidelines for Hemodialysis Adequacy.Am J Kidney Dis1997; 30: S15–66.
5.
PetersV., ClemonsG., AugustineB.“Fistula First” as a CMS breakthrough initiative: improving vascular access through collaboration.Nephrol Nursing J2005; 32: 686–7.
6.
Van TrichtI., De WachterD., TordoirJ., VerdonckP.Hemodynamics and complications encountered with arteriovenous fistulas and grafts as vascular access for hemodialysis: a review.Ann Biomed Eng2005; 33: 1142–57.
7.
FalkA.Maintenance and salvage of arteriovenous fistulas.J Vasc Interv Radiol2006; 17: 807–13.
8.
PatelS.T., HughesJ., MillsJ.L.Failure of arteriovenous fistula maturation: an unintended consequence of exceeding dialysis outcome quality initiative guidelines for hemodialysis access.J Vasc Surg2003; 38: 439–45.